Braddock syndrome
diseaseOn this page
Also known as Vater-like syndrome with pulmonary hypertension, abnormal ears and growth deficiency
Summary
Braddock syndrome (MONDO:0012032) is a disease. A subtype of pulmonary hypertension — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
- Phenotypes (HPO): 24
Clinical features
Epidemiology
Prevalence records
2 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Cases/families | 2 | Worldwide | Validated | |
| Point prevalence | <1 / 1 000 000 | Worldwide | Validated |
Signs & symptoms
Clinical features (HPO)
24 HPO clinical features (Orphanet curated; top 24 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0000358 | Posteriorly rotated ears | Very frequent (80-99%) |
| HP:0000396 | Overfolded helix | Very frequent (80-99%) |
| HP:0000592 | Blue sclerae | Very frequent (80-99%) |
| HP:0000767 | Pectus excavatum | Very frequent (80-99%) |
| HP:0000921 | Missing ribs | Very frequent (80-99%) |
| HP:0001511 | Intrauterine growth retardation | Very frequent (80-99%) |
| HP:0002092 | Pulmonary arterial hypertension | Very frequent (80-99%) |
| HP:0002206 | Pulmonary fibrosis | Very frequent (80-99%) |
| HP:0002937 | Hemivertebrae | Very frequent (80-99%) |
| HP:0005950 | Laryngeal web | Very frequent (80-99%) |
| HP:0000122 | Unilateral renal agenesis | Frequent (30-79%) |
| HP:0000286 | Epicanthus | Frequent (30-79%) |
| HP:0000347 | Micrognathia | Frequent (30-79%) |
| HP:0000470 | Short neck | Frequent (30-79%) |
| HP:0000581 | Blepharophimosis | Frequent (30-79%) |
| HP:0000601 | Hypotelorism | Frequent (30-79%) |
| HP:0001177 | Preaxial hand polydactyly | Frequent (30-79%) |
| HP:0001508 | Failure to thrive | Frequent (30-79%) |
| HP:0002643 | Neonatal respiratory distress | Frequent (30-79%) |
| HP:0002650 | Scoliosis | Frequent (30-79%) |
| HP:0004322 | Short stature | Frequent (30-79%) |
| HP:0005988 | Congenital muscular torticollis | Frequent (30-79%) |
| HP:0006610 | Wide intermamillary distance | Frequent (30-79%) |
| HP:0010720 | Abnormal hair pattern | Frequent (30-79%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | Braddock syndrome |
| Mondo ID | MONDO:0012032 |
| MeSH | C564244 |
| OMIM | 608406 |
| Orphanet | 52047 |
| SNOMED CT | 720575002 |
| UMLS | C1842082 |
| MedGen | 333986 |
| GARD | 0016652 |
| Is cancer (heuristic) | no |
Also known as: Vater-like syndrome with pulmonary hypertension, abnormal ears and growth deficiency
Disease family
This is a subtype of pulmonary hypertension. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › cardiovascular disorder › vascular disorder › arterial disorder › hypertensive disorder › pulmonary hypertension › Braddock syndrome
Related subtypes (5): chronic thromboembolic pulmonary hypertension, hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome, pulmonary arterial hypertension, pulmonary hypertension owing to lung disease and/or hypoxia, pulmonary hypertension, neonatal
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.